Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | I682L |
Impact List | missense |
Protein Effect | no effect - predicted |
Gene Variant Descriptions | JAK2 I682L lies within protein kinase domain 1 of the Jak2 protein (UniProt.org). I682L demonstrates enzyme kinetics and structural stability similar to wild-type Jak2 in in vitro assays (PMID: 25940527), and therefore, is predicted to have no effect on Jak2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 I682L |
Transcript | NM_004972.4 |
gDNA | chr9:g.5078357A>C |
cDNA | c.2044A>C |
Protein | p.I682L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322196.1 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5078357A>C | c.2044A>C | p.I682L | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|